A novel multiple biomarker panel for the early detection of high-grade serous ovarian carcinoma

News

A novel multiple biomarker panel for the early detection of high-grade serous ovarian carcinoma

A novel multiple biomarker panel for the early detection of high-grade serous ovarian carcinoma

A study supported by grants from Tina’s Wish to Alessandro D. Santin, MD and Abhijit Patel, MD, PhD of Yale Caner Center was recently published in Elsevier.

Paper conclusions: Their four-marker panel, CA125, HE4, E-CAD, and IL-6, shows potential in detecting serous ovarian cancer at earlier stages.

CLICK HERE for the full paper.

CLICK HERE to learn more about Dr. Santin and Dr. Patel’s research being funded by Tina’s Wish.